Boryung Corporation (KRX:003850)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,610.00
+370.00 (4.49%)
At close: Nov 26, 2025
-14.75%
Market Cap726.53B
Revenue (ttm)1.03T
Net Income (ttm)56.45B
Shares Out84.48M
EPS (ttm)688.80
PE Ratio12.49
Forward PEn/a
Dividend100.00 (1.21%)
Ex-Dividend DateDec 29, 2025
Volume369,407
Average Volume234,034
Open8,320.00
Previous Close8,240.00
Day's Range8,280.00 - 8,620.00
52-Week Range7,680.00 - 11,100.00
Beta0.30
RSI50.56
Earnings DateNov 13, 2025

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1957
Employees 1,533
Stock Exchange Korea Stock Exchange
Ticker Symbol 003850
Full Company Profile

Financial Performance

In 2024, Boryung's revenue was 1.02 trillion, an increase of 18.32% compared to the previous year's 859.63 billion. Earnings were 69.63 billion, an increase of 73.20%.

Financial Statements

News

There is no news available yet.